학술논문

A potent FGFR4-targeted antibody-drug conjugate therapy for patients with rhabdomyosarcoma and other cancers expressing FGFR4
Document Type
Journal
Source
CANCER RESEARCH; APR 1 2024, 84 7, 3p. Supplement: S
Subject
Language
English
ISSN
15387445